NCT03586115View on ClinicalTrials.gov

Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

March 21, 2020

Study Completion Date

April 30, 2020

Conditions
Hepatic EncephalopathyMinimal Brain Dysfunction
Interventions
DEVICE

Critical flicker frequency assessment

All patients will undergo critical flicker frequency assessment to evaluate the presence of minimal hepatic encephalopaty. In addition, hepatic elastometry will be assessed to evaluate the presence of advanced liver fibrosis.

Trial Locations (1)

70124

Policlinic Hospital, Bari

All Listed Sponsors
lead

University of Bari

OTHER

NCT03586115 - Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian | Biotech Hunter | Biotech Hunter